adverse events New IBD Adverse Drug Response Risk Gene Identified Genome- and exome-wide association analysis on inflammatory bowel disease patients with or without thiopurine-induced myelosuppression revealed new and known risk genes. Warfarin Bleeding Risk SNPs Identified in African Americans A case-control GWAS of individuals of African descent led to four chromosome 6 SNPs with apparent ties to bleeding risk associated with warfarin anticoagulants. Estonian Team Pairs Pharmacogenomics, EHRs to Reduce Adverse Drug Reactions Premium The effort is already bearing fruit, as the team has been able to validate several variants known to be connected with adverse drug reactions. Pharmacogenomics Consortium Aims to Make Testing Ubiquitous for European Patients Premium Backed by €15 million in EU funding, the Ubiquitous Pharmacogenomics Consortium seeks to implement preemptive testing at seven healthcare systems by 2020. Gene Variant Linked to Childhood Cancer Drug's Cardio Side Effects An international team detected a variant associated with anthracycline-induced cardiotoxicity in a study of more than 450 children treated with the drug. Mar 31, 2015 Stanford Researchers Turn to Crowdsourcing to Rank Severity of Adverse Drug Reactions Premium Jul 11, 2012 Expression Analysis, HemoShear Team on Database for Drug Response Sep 13, 2011 GNS Healthcare, Brigham & Women's Collaborate on Adverse Drug Events Prediction Jun 23, 2011 iSAEC Partners with Catholic Health Initiatives Jun 15, 2011 SAEC Partners with Shanghai University to Explore Ethnic Variation in Adverse Drug Reactions Premium Jun 15, 2011 SAEC, Chinese University Partner on Genetic Research into Drug-induced Serious Adverse Events Feb 2, 2011 iSAEC Collaborates with HMO Network Dec 23, 2010 Spartan Bioscience Gets CE IVD Mark for 'Sample-to-Answer' CYP2C19 Testing Platform Premium Sep 9, 2010 SAEC Partners with Liverpool, Newcastle Universities on PGx Jul 26, 2010 CMS Approves Iverson Clinical Study of Genetic Testing for Warfarin Jul 20, 2010 Novartis Study Detects Drug-Related Liver Injury Risk Variants Mar 24, 2010 FDA Advisory Panel Mulls Genomic-Driven Strategies for Predictive Safety, Sample Collection Premium Oct 21, 2009 SAEC Teams with HMOs on PGx Study Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.